The present technology provides methods of preventing or treating an ischemia-reperfusion injury, such as acute myocardial infarction injury, in a mammalian subject. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide and a second active agent to subjects in need thereof.
